Osteoporosis, bone & mineral

Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis

Osteoporos IntPublished Systematic review and meta-analysis of observational studies

Authors' conclusion

Surgery without discontinuing antiplatelets may be safe. Early surgery after discontinuing antiplatelets could reduce hospital stays without adverse outcomes. Randomized trials are needed to confirm these findings.

Study context

Population
Hip fracture patients aged ≥65 years taking antiplatelets or direct oral anticoagulants (DOACs); 13 observational studies from 9 countries; searches to November 2024
Participants
885 patients13 observational studies
Comparison
Continuation vs discontinuation of antiplatelets or DOACs before hip fracture surgery; early vs delayed surgery after discontinuation
Outcome
Transfusion rates
Methodological detailsrandom-effects model, Newcastle-Ottawa Scale risk of bias
  • Random-effects model
  • Newcastle-Ottawa Scale risk of bias

Pooled result

As reported in the abstract

Transfusion rates in patients who continued the medication: no significant differences, OR

0.87

95% CI 0.37 to 2.03

Further pooled results

OutcomeEstimate
Transfusion, DOAC users: earlyvs delayed surgeryOR 1.09 (95% CI 0.56–2.09)
30-day mortality, DOAC users: earlyvs delayed surgeryOR 1.53 (95% CI 0.45–5.19)
Transfusion and in-hospital mortality, antiplatelet users: surgery within 48 h of discontinuation vs delayed surgeryEarly surgeryvs Delayed surgeryNo increaseOR (transfusion) 0.75 (95% CI 0.04–13.73)
Transfusion and in-hospital mortality, antiplatelet users: surgery within 48 h of discontinuation vs delayed surgeryEarly surgeryvs Delayed surgeryNo increaseOR (in-hospital mortality) 0.49 (95% CI 0.02–13.52)
OutcomeMean difference (days) (95% CI)
Hospital stay, antiplatelet users: surgery within 48 h of discontinuation vs delayed surgery- 5.71 (- 8.36 to - 3.06)

Original publication

Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis. Osteoporos Int. Published 7 August 2025. doi:10.1007/s00198-025-07572-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.